Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

CN Energy's Pathenbot launches intelligent robotic cargo sorting in the US with a 100,000-unit order.

Market News
22 May 2026
Prnewswire
View Source
Bullish
pluang ai news

CN Energy Group's subsidiary Pathenbot has signed an order to provide intelligent robotic cargo sorting services in the United States, marking the commercial launch of these services. The initial order covers 100,000 units and includes barcode scanning, SKU recognition, cargo classification, and operational data support. This milestone represents Pathenbot's expansion in smart logistics and warehouse robotics, with plans to extend deployment from the western US to central and eastern regions. The move highlights CN Energy's strategic growth in automation and smart logistics solutions in North America.

More News

US stock futures rise amid cautious optimism on US-Iran peace talks and strong earnings reports.

US stock futures rise amid cautious optimism on US-Iran peace talks and strong earnings reports.

US stock futures gained as investors reacted to positive earnings from companies like Ross Stores, Zoom, and Take-Two Interactive, alongside cautious optimism about US-Iran peace talks. However, uncertainty remains due to Iran's firm stance on uraniu...

Company Fundamentals
Bullish
1 hour ago
BioNTech reveals promising late-stage cancer drug data at ASCO 2026, advancing treatments for lung and ovarian cancers.

BioNTech reveals promising late-stage cancer drug data at ASCO 2026, advancing treatments for lung and ovarian cancers.

BioNTech presented encouraging clinical data for its late-stage cancer drug candidates Pumitamig and Gotistobart at the ASCO 2026 meeting. Pumitamig showed promising anti-tumor activity in a Phase 2/3 study for first-line treatment of non-small cell ...

Market News
Bullish
1 hour ago
BioNTech to present promising late-stage cancer drug data at 2026 ASCO meeting

BioNTech to present promising late-stage cancer drug data at 2026 ASCO meeting

BioNTech will showcase new clinical data for its late-stage oncology drugs pumitamig and gotistobart at the 2026 ASCO Annual Meeting. Pumitamig showed encouraging anti-tumor activity in first-line non-small cell lung cancer, while gotistobart demonst...

Market News
Bullish
1 hour ago
Africa's alternative lending market to grow to $8.1B by 2029, driven by digital credit and regulatory reforms.

Africa's alternative lending market to grow to $8.1B by 2029, driven by digital credit and regulatory reforms.

Africa's alternative lending market is projected to grow from $4.8 billion in 2025 to $8.1 billion by 2029, with a CAGR of 13.9%. Growth is fueled by expanding digital credit via mobile money, tighter regulations in Nigeria, Kenya, and Ghana, and inc...

Market News
Bullish
1 hour ago
S&P 500 edges up as oil prices fall and Treasury yields ease, boosting investor confidence.

S&P 500 edges up as oil prices fall and Treasury yields ease, boosting investor confidence.

The S&P 500 rose 0.17% to close at 7,445.72, continuing a two-day gain supported by falling oil prices and cooling Treasury yields, which helped ease inflation worries. Investor sentiment improved amid hopes for a resolution to the U.S.-Iran conflict...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App